Charles Schwab’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-210,259
| Closed | -$20.4M | – | 3192 |
|
|
2019
Q3 | $20.4M | Buy |
210,259
+15,755
| +8% | +$1.53M | 0.01% | 1134 |
|
|
2019
Q2 | $19.9M | Buy |
194,504
+8,709
| +5% | +$892K | 0.01% | 1142 |
|
|
2019
Q1 | $21.2M | Buy |
185,795
+11,495
| +7% | +$1.31M | 0.01% | 1064 |
|
|
2018
Q4 | $6.82M | Sell |
174,300
-1,101
| -0.6% | -$43.1K | 0.01% | 1712 |
|
|
2018
Q3 | $9.57M | Buy |
175,401
+10,137
| +6% | +$553K | 0.01% | 1672 |
|
|
2018
Q2 | $13.7M | Buy |
165,264
+13,894
| +9% | +$1.15M | 0.01% | 1374 |
|
|
2018
Q1 | $10.1M | Buy |
151,370
+6,738
| +5% | +$449K | 0.01% | 1488 |
|
|
2017
Q4 | $7.44M | Buy |
144,632
+15,062
| +12% | +$774K | 0.01% | 1677 |
|
|
2017
Q3 | $11.6M | Buy |
129,570
+34,650
| +37% | +$3.09M | 0.01% | 1316 |
|
|
2017
Q2 | $5.67M | Buy |
94,920
+7,169
| +8% | +$428K | 0.01% | 1739 |
|
|
2017
Q1 | $4.68M | Buy |
87,751
+7,605
| +9% | +$406K | ﹤0.01% | 1795 |
|
|
2016
Q4 | $4M | Buy |
80,146
+4,216
| +6% | +$210K | ﹤0.01% | 1862 |
|
|
2016
Q3 | $4.56M | Buy |
75,930
+13,642
| +22% | +$819K | 0.01% | 1704 |
|
|
2016
Q2 | $3.19M | Buy |
62,288
+20,920
| +51% | +$1.07M | ﹤0.01% | 1835 |
|
|
2016
Q1 | $1.22M | Buy |
41,368
+6,829
| +20% | +$202K | ﹤0.01% | 2259 |
|
|
2015
Q4 | $1.57M | Buy |
34,539
+1,283
| +4% | +$58.1K | ﹤0.01% | 2195 |
|
|
2015
Q3 | $1.39M | Buy |
33,256
+13,180
| +66% | +$550K | ﹤0.01% | 2253 |
|
|
2015
Q2 | $1.21M | Buy |
20,076
+13,074
| +187% | +$788K | ﹤0.01% | 2331 |
|
|
2015
Q1 | $543K | Buy |
+7,002
| New | +$543K | ﹤0.01% | 2599 |
|